← Back to all trials
Completed
NCT05596617
Safety and Efficacy of Medications COVID-19
Conditions: Severe Covid-19
Sex: All
Phase: NA
Enrollment: 335
Sponsor: Hospital San Carlos, Madrid
Location: Spain
Summary
We performed a quasi-experimental open-label pragmatic study alternating standard of care (SOC) and oral bedtime melatonin (OBM) at different high doses over 4 consecutive time periods enrolling all consecutive RT-PCR SARS-CoV-2 severe Covid-19 admissions.
Eligibility Criteria
Inclusion Criteria:Positive RT-PCR for SARS-CoV-2Exclusion Criteria:Anticipated death within 48 hours or paliative care
Source: ClinicalTrials.gov (NCT05596617). StuddyBuddy aggregates publicly available trial information.
